Association of baseline disability and major adverse outcomes in patients with atrial fibrillation: an analysis from the SPORTIF trials

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Associate Professor Marco Proietti

University of Milan, Milan (Italy)

12 More presentations in this session

Presentation thumbnail

Risk of major gastrointestinal bleed in relation to vascular disease risk in 0.5M UK Biobank participants

Doctor I. Hammami (Oxford, GB)

Presentation thumbnail

Anticoagulation strategies based on warfarin or direct oral anticoagulants compared to major hemorrhagic events: the relevance of patients aged 75 years or older.

Doctor A. Conti (Massa, IT)

Abstract Slides

Presentation thumbnail

CHA(2)DS(2)-VASc score calibration in anticoagulated vs non-anticoagulated patients in a healthcare area

Doctor A. Baluja (Santiago de Compostela, ES)

Abstract Slides

Presentation thumbnail

The effect of hypertension and metabolic syndrome on left atrial function in patients with paroxysmal atrial fibrillation undergoing catheter ablation

Doctor A. Katbeh (Damascus, SY)

Abstract Slides

Presentation thumbnail

Nocturnal hypoxemic burden in ambulatory patients with atrial fibrillation: a disease-orientated assessment of sleep-disordered breathing severity.

Professor D. Linz (Maastricht, NL)

Access the full session

Session thumbnail

Poster Session 1 - Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Presentation

Making personalised prevention everyone's business

Webinar

Risk assessment and lipid management in primary prevention

Congress Presentation

Saving hearts, extending lives: the impact of risk prevention on lifetime estimates in Germany

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources